The CDC has issued its updated 2026 adult immunization schedule, adding refined RSV vaccine eligibility, annual COVID-19 boosters, and clarified pneumococcal options. The changes aim to simplify ...

The CDC’s 2026 adult immunization schedule adds earlier shingles vaccination, widens RSV vaccine eligibility, and adopts an annual COVID-19 booster model. These updates respond to shifting disease ...

Add Yahoo as a preferred source to see more of our stories on Google. It started with a cough that wouldn’t go away. Before she knew it, Karyne Jones was hospitalized with pneumonia in January 2018.

ATLANTA — The Centers for Disease Control and Prevention has updated its recommendation on the use of the Respiratory Syncytial Virus (RSV) vaccines for adults 60 and older who did not get the vaccine ...

The CDC has made new recommendations on who might need a second dose of the new COVID-19 vaccine. The new recommendations impact those who are 65 and older, as well as people who are moderately or ...

The ACIP recommends vaccination for all adults aged 50 years and older who have not previously received a pneumococcal conjugate vaccine or whose previous vaccination history is unknown. The Centers ...

As a CDC advisory panel sets new recommendations for the COVID vaccines this fall, seniors and adults with underlying conditions can still receive the updated COVID vaccines without a prescription. A ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Capvaxive, Merck’s 21-valent pneumococcal vaccine, which is specifically made to protect ...